Tue, Jul 22, 2014, 10:44 AM EDT - U.S. Markets close in 5 hrs 16 mins

Recent

% | $
Click the to save as a favorite.

Curis, Inc. Message Board

  • earl5678 earl5678 Aug 18, 2012 6:10 PM Flag

    Any chance that EMA will approve Erivedge this week?

    It is hard to understand how an inoperable fatal disease with a proven cure would take such a long time to gain regulatory approval?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Would you please stop this line of posts? You know from direct quotes from Curis management and Roche management that there IS NO CHANCE of approval this week. At best it is end of 2012 or early 2013 according to both companies. PLEASE STOP SETTING PEOPLE UP FOR DISAPPOINTMENT REGARDING THIS.

      • 1 Reply to desert_dweller93
      • Desert, the stock market is all about speculation, one can always speculate. How else can you explain every biotech on my list, and I do mean every , outperforming CRIS? Everyone I know on twitter is bashing PPHM right now and the stock is going parabolic. I got stuck a long time ago with a token 200 shares because trade4aliving was really good at one time, I would not dare touch this thing now, yet here we are. Their market cap is about to overtake the Curis because the market does not see much speculation CRIS but somehow, thru some rose colored glasses, they see it yes PPHM, freaking unreal. That is what all of us here have to learn. You should never fall in love with a stock. That's one of Jesse most important rules. But if you get bitten, and all indications are that you are right and the market is wrong, then you have to be willing and good enough to make your money elsewhere while you wait. Thank God for AMRN, AFFY, ECYT, SPPI, ARRY. But even AMRN & APPI, my goodness, your timing had to be perfect or you got crushed.

 
CRIS
1.77+0.03(+1.72%)10:43 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.